You are using an old and unsupported browser. Upgrade to a modern browser for a better experience

Times are shown in your local time zone (GMT )

PSMA-PET - Diagnostics, Theranostics & An Update on Australian studies

Session Topic


PSMA-PET presents the most exciting tool for the diagnosis and treatment of prostate cancer in many years.  This session explores the cutting edge of diagnostics and theranostics with the specialists at the forefront.  The first talk outlines the importance of standardised reporting – why we get false positives and false negatives and how to avoid inaccurate results.  A series of world-first papers emanating from Australia are then discussed – from the staging of metastatic disease (Pro-PSMA study) to the evaluation of the cancer within the prostate (PRIMARY study), to the futuristic treatment of prostate cancer using Lutetium-PSMA for both advanced and localised disease.

This session is proudly supported by AstraZeneca 
Session Program
#21st Asia-Pacific Prostate Conference Virtual
APCC 2020
#21st Asia-Pacific Prostate Conference Virtual